Boothbay Fund Management, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$7.59 - $17.47 $224,664 - $517,111	29,600 New	29,600 $438,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $243,886 - $376,270	-19,700 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $81,400 - $106,520	-4,000 Reduced 16.88%	19,700 $486,000
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $387,020 - $783,759	23,700 New	23,700 $617,000

323

239M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.52B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.